The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
An endocannabinoid mechanism for stress-induced analgesia
Open accessAbstract
Acute stress suppresses pain by activating brain pathways that engage opioid or non-opioid mechanisms. Here we show that an opioid-independent form of this phenomenon, termed stress-induced analgesia, is mediated by the release of endogenous marijuana-like (cannabinoid) compounds in the brain. Blockade of cannabinoid CB(1) receptors in the periaqueductal grey matter of the midbrain prevents non-opioid stress-induced analgesia. In this region, stress elicits the rapid formation of two endogenous cannabinoids, the lipids 2-arachidonoylglycerol (2-AG) and anandamide. A newly developed inhibitor of the 2-AG-deactivating enzyme, monoacylglycerol lipase, selectively increases 2-AG concentrations and, when injected into the periaqueductal grey matter, enhances stress-induced analgesia in a CB1-dependent manner. Inhibitors of the anandamide-deactivating enzyme fatty-acid amide hydrolase, which selectively elevate anandamide concentrations, exert similar effects. Our results indicate that the coordinated release of 2-AG and anandamide in the periaqueductal grey matter might mediate opioid-independent stress-induced analgesia. These studies also identify monoacylglycerol lipase as a previously unrecognized therapeutic target.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Monoacylglycerol lipase (MGL) is a key enzyme implicated in the hydrolysis of 2-AG.33, 34”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [33]
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Self-citationImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Self-citationBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Self-citationIncreased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Self-citation
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Walker, J. M. & Hohmann, A. G. in Cannabinoids—Handbook of Experimental Pharmacology (ed. Pertwee, R.) 509–554 (Springer, Berlin, 2005)
Cited by
Sorted by citations
Items 101–200 of 795
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Mock, E. D., Gagestein, B., & van der Stelt, M. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101194 · Cited by 164
Raehal, K. M., & Bohn, L. M. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-41199-1_22 · Cited by 154
“2005), CB1 receptors (CB1R) in the central nervous system play the most pronounced role in mediating the analgesic, motor, and psychoactive effects of cannabinoids (Zimmer et al. 1999; Kelly and Chapman 2001; Hohmann et al. 2005; Pertwee 2005; Suplita et al. 2006; Dziaduleqicz et al. 2007).”
BackgroundWang, X., Sarris, K., Kage, K., Zhang, D., Brown, S. P., Kolasa, T., Surowy, C. S., El-Kouhen, O. F., Muchmore, S. W., Brioni, J. D., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801042a · Cited by 154
Hu, S. S., Bradshaw, H. B., Chen, J. S., Tan, B., & Walker, J. M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.33 · Cited by 151
Grabner, G. F., Zimmermann, R., Schicho, R., & Taschler, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.033 · Cited by 153
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 159
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray
Moreira, F. A., de Aguiar, D. C., & Guimarães, F. S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.013 · Cited by 153
Matuszak, N., Muccioli, G. G., Labar, G., & Lambert, D. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900461w · Cited by 147
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 147
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction
de Oliveira Alvares, L., Pasqualini Genro, B., Diehl, F., Molina, V. A., & Quillfeldt, J. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.005 · Cited by 143
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Gil-Ordóñez, A., Martín‐Fontecha, M., Ortega‐Gutiérrez, S., & López-Rodríguez, M. L. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.036 · Cited by 146
Communication networks in the brain: neurons, receptors, neurotransmitters, and alcohol.
Lovinger, D. M. (2008) · Europe PMC (PubMed Central) · Cited by 137
Wang, M., Hill, M. N., Zhang, L., Gorzalka, B. B., Hillard, C. J., & Alger, B. E. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111409606 · Cited by 137
Stress regulates endocannabinoid-CB1 receptor signaling
Hillard, C. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.001 · Cited by 144
The Endocannabinoid Signaling System in the CNS
Hillard, C. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.001 · Cited by 144
Gao, Z., Chen, W., Liu, M., Chen, X., Wan, L., Zhang, X., Yuan, L., Lin, J.-K., Wang, M., Zhou, L., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.11.010 · Cited by 136
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
Zhang, J., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800524200 · Cited by 136
The complications of promiscuity: endocannabinoid action and metabolism
Alexander, S. P. H., & Kendall, D. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707456 · Cited by 136
Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ
Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 136
Role of the endocannabinoid system in depression and suicide
Vinod, K. Y., & Hungund, B. L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.006 · Cited by 132
Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy
Khasabova, I. A., Khasabov, S., Paz, J., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0403-12.2012 · Cited by 129
Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
Kasatkina, L. A., Rittchen, S., & Sturm, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115431 · Cited by 133
More surprises lying ahead. The endocannabinoids keep us guessing
Piomelli, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.026 · Cited by 128
Self-citationIgnatowska‐Jankowska, B. M., Ghosh, S., Crowe, M. S., Kinsey, S. G., Niphakis, M. J., Abdullah, R. A., Tao, Q., O' Neal, S. T., Walentiny, D. M., Wiley, J. L., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12298 · Cited by 128
Biosynthesis and degradation of the endocannabinoid 2‐arachidonoylglycerol
Ueda, N., Tsuboi, K., Uyama, T., & Ohnishi, T. (2010) · BioFactors · doi:10.1002/biof.131 · Cited by 133
Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127
TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation
Caterina, M. J. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000919 · Cited by 126
Suárez, J., Bermúdez‐Silva, F. J., Mackie, K., Ledent, C. A., Zimmer, A., Cravatt, B. F., & de Fonseca, F. R. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21774 · Cited by 126
Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 130
Guindon, J., Guijarro, A. I., Piomelli, D., & Hohmann, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01192.x · Cited by 120
Self-citationSchlosburg, J. E., Carlson, B. L. A., Ramesh, D., Abdullah, R. A., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9110-7 · Cited by 120
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Leo, L. M., & Abood, M. E. (2021) · Molecules · doi:10.3390/molecules26175413 · Cited by 121
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
King, A. R., Dotsey, E. Y., Lodola, A., Jung, K., Ghomian, A., Qiu, Y., Fu, J., Mor, M., & Piomelli, D. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.09.012 · Cited by 117
Self-citationTuo, W., Leleu‐Chavain, N., Spencer, J., Sansook, S., Millet, R., & Chavatte, P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00538 · Cited by 116
Małek, N., Popiołek-Barczyk, K., Mika, J., Przewłocka, B., & Starowicz, K. (2015) · Neural Plasticity · doi:10.1155/2015/130639 · Cited by 114
Activation of the endocannabinoid system by organophosphorus nerve agents
Nomura, D. K., Blankman, J. L., Simon, G. M., Fujioka, K., Issa, R. S., Ward, A. M., Cravatt, B. F., & Casida, J. E. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.86 · Cited by 112
Cippitelli, A., Cannella, N., Braconi, S., Duranti, A., Tontini, A., Bilbao, A., de Fonseca, F. R., Piomelli, D., & Ciccocioppo, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1104-0 · Cited by 114
Self-citationRossi, S., Chiara, V. D., Musella, A., Kusayanagi, H., Mataluni, G., Bernardi, G., Usiello, A., & Centonze, D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5346-07.2008 · Cited by 119
Endocannabinoid Signaling in the Control of Social Behavior
Don, W., Allsop, S. A., Tye, K. M., & Piomelli, D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.005 · Cited by 120
Self-citationThe Multifaceted Role of Epoxide Hydrolases in Human Health and Disease
Gautheron, J., & Jéru, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010013 · Cited by 111
Terzian, A. L. B., de Aguiar, D. C., Guimarães, F. S., & Moreira, F. A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.11.004 · Cited by 111
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Labar, G., Wouters, J., & Lambert, D. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791859414 · Cited by 111
Fattore, L., Spano, M. S., Deiana, S., Melis, V., Cossu, G., Fadda, P., & Fratta, W. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.05.003 · Cited by 110
Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase
Naidu, P. S., Kinsey, S. G., Guo, T. L., Cravatt, B. F., & Lichtman, A. H. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164806 · Cited by 108
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 108
King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108
Self-citationFAAH and anandamide: is 2-AG really the odd one out?
Marzo, V. D., & Maccarrone, M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.001 · Cited by 109
Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 114
CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay
Muccioli, G. G., Labar, G., & Lambert, D. M. (2008) · ChemBioChem · doi:10.1002/cbic.200800428 · Cited by 106
Bedse, G., Hartley, N. D., Neale, E., Gaulden, A. D., Patrick, T. A., Kingsley, P. J., Uddin, M. J., Plath, N., Marnett, L. J., & Patel, S. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.002 · Cited by 108
Suplita, R. L., Farthing, J. N., Gutierrez, T., & Hohmann, A. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.007 · Cited by 104
Self-citationCannabinoid signaling in health and disease
Lu, Y., & Anderson, H. D. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0346 · Cited by 105
Vachon‐Presseau, É., Martel, M. O., Roy, M., Caron, E., Albouy, G., Marin, M., Plante, I., Sullivan, M. J. L., LUPIEN, S. J., & Rainville, P. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4584-12.2013 · Cited by 105
Guindon, J., Desroches, J., & Beaulieu, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706990 · Cited by 102
Magotti, P., Bauer, I., Igarashi, M., Babagoli, M. A., Marotta, R., Piomelli, D., & Garau, G. (2015) · Structure · doi:10.1016/j.str.2014.12.018 · Cited by 100
Self-citationImpact of stress, fear and anxiety on the nociceptive responses of larval zebrafish
López-Luna, J., Al-Jubouri, Q., Al‐Nuaimy, W., & Sneddon, L. U. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181010 · Cited by 99
Alvares, L. D. O., Genro, B. P., Diehl, F., & Quillfeldt, J. A. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.01.009 · Cited by 99
Endocannabinoids: The silent partner of glucocorticoids in the synapse
Hill, M. N., & McEwen, B. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901519106 · Cited by 98
Comelli, F., Giagnoni, G., Bettoni, I., Colleoni, M., & Costa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707425 · Cited by 97
La Rana, G., Russo, R., Campolongo, P., Bortolato, M., Mangieri, R. A., Cuomo, V., Iacono, A., Raso, G. M., Meli, R., Piomelli, D., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100792 · Cited by 97
“…blockade enhances pain behaviors in several pain models (Calig-nano et al., 1998; Strangman et al., 1998; for contrasting results, see Beaulieu et al., 2000) and abrogates nonopioid stress-induced analgesia (Hohmann et al., 2005), suggesting the existence of an analgesic endocannabinoid tone.”
BackgroundInfluentialSelf-citationChin, C.-L., Tovcimak, A. E., Hradil, V. P., Seifert, T. R., Hollingsworth, P. R., Chandran, P., Zhu, C. Z., Gauvin, D. M., Pai, M., Wetter, J. B., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707506 · Cited by 96
Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro
Vandevoorde, S., Jonsson, K., Labar, G., Persson, E., Lambert, D. M., & Fowler, C. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706971 · Cited by 96
Monoacylglycerol lipase – a target for drug development?
Fowler, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01950.x · Cited by 96
Alvares, L. D. O., Genro, B. P., Breda, R. V., Pedroso, M. F., da Costa, J. C., & Quillfeldt, J. A. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.101 · Cited by 95
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia
Nyilas, R., Gregg, L. C., Mackie, K., Watanabe, M., Zimmer, A., Hohmann, A. G., & Katona, I. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06751.x · Cited by 94
Self-citationRimmerman, N., Bradshaw, H. B., Hughes, V., Chen, J. S.-C., Hu, S. S., McHugh, D., Vefring, E., Jahnsen, J. A., Thompson, E. L., Masuda, K. R., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045997 · Cited by 96
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
The endocannabinoid system as a target for the treatment of cannabis dependence
Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.018 · Cited by 94
Self-citationOlango, W., Roche, M., Ford, G., Harhen, B., & Finn, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01478.x · Cited by 93
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Karst, M., Wippermann, S., & Ahrens, J. (2010) · Drugs · doi:10.2165/11585260-000000000-00000 · Cited by 91
King, A., Lodola, A., Carmi, C., Fu, J., Mor, M., & Piomelli, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00276.x · Cited by 91
Self-citationEndocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
Bambico, F. R., Duranti, A., Tontini, A., Tarzia, G., & Gobbi, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168029 · Cited by 94
Self-citationCrawford, L. S., Mills, E. P., Hanson, T., Macey, P. M., Glarin, R., Macefield, V. G., Keay, K. A., & Henderson, L. A. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0806-21.2021 · Cited by 92
Mazzardo‐Martins, L., Martins, D. F., Marcon, R., dos Santos, U. D., Speckhann, B., Gadotti, V. M., Sigwalt, A. R., Guglielmo, L. G. A., & Santos, A. R. S. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.03.015 · Cited by 90
Khasabova, I. A., Khasabov, S. G., Harding-Rose, C., Coicou, L. G., Seybold, B., Lindberg, A. E., Steevens, C. D., Simone, D. A., & Seybold, V. S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2847-08.2008 · Cited by 90
Midbrain vlPAG inhibits rVLM cardiovascular sympathoexcitatory responses during electroacupuncture
Tjen‐A‐Looi, S. C., Li, P., & Longhurst, J. C. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01329.2005 · Cited by 90
Sciolino, N. R., Bortolato, M., Eisenstein, S. A., Fu, J., Oveisi, F., Hohmann, A. G., & Piomelli, D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.007 · Cited by 89
Self-citationSelective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice
Ignatowska-Jankowska, B. M., Wilkerson, J. L., Mustafa, M. A., Abdullah, R. A., Niphakis, M. J., Wiley, J. L., Cravatt, B. F., & Lichtman, A. H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222315 · Cited by 92
The CB1 Receptor as the Cornerstone of Exostasis
Piazza, P. V., Cota, D., & Marsicano, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.002 · Cited by 100
Finn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 91
The Brainstem and Nociceptive Modulation
Heinricher, M. M., & Ingram, S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370880-9.00183-3 · Cited by 87
Kinsey, S. G., Naidu, P. S., Cravatt, B. F., Dudley, D. T., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.022 · Cited by 87
The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress
Corcoran, L., Roche, M., & Finn, D. P. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.003 · Cited by 90
Brindisi, M., Maramai, S., Gemma, S., Brogi, S., Grillo, A., Di Cesare Mannelli, L., Gabellieri, E., Lamponi, S., Saponara, S., Gorelli, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01812 · Cited by 86
Self-citationFrom endocannabinoid profiling to ‘endocannabinoid therapeutics’
Ligresti, A., Petrosino, S., & Marzo, V. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.615 · Cited by 88
Fatty Acid Amide Hydrolase: From Characterization to Therapeutics
Labar, G., & Michaux, C. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790157 · Cited by 86
Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83
Self-citationRoche, M., O'Connor, E., Diskin, C., & Finn, D. P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05861.x · Cited by 83
Kohnz, R. A., & Nomura, D. K. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00047a · Cited by 86
Rossi, S., De Chiara, V., Musella, A., Sacchetti, L., Cantarella, C., Castelli, M., Cavasinni, F., Motta, C., Studer, V., Bernardi, G., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064196 · Cited by 82
Microglia produce and hydrolyze palmitoylethanolamide
Muccioli, G. G., & Stella, N. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.015 · Cited by 83
Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
Gilbert, G. L., Kim, H. J., Waataja, J. J., & Thayer, S. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.011 · Cited by 81
Contet, C., Gavériaux‐Ruff, C., Matifas, A., Caradec, C., Champy, M., & Kieffer, B. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300934 · Cited by 81
Anandamide and neutrophil function in patients with fibromyalgia
Kaufmann, I., Schelling, G., Eisner, C. B., Richter, H. P., Krauseneck, T., Vogeser, M., Hauer, D., Campolongo, P., Choukèr, A., Beyer, A., et al. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.009 · Cited by 80
Richards, J. R., Lapoint, J. M., & Putze, G. B. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1349910 · Cited by 80
Wilson-Poe, A. R., Morgan, M. M., Aicher, S. A., & Hegarty, D. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.038 · Cited by 79
Gregg, L. C., Jung, K., Spradley, J. M., Nyilas, R., Suplita, R. L., Zimmer, A., Watanabe, M., Mackie, K., Katona, I., Piomelli, D., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0013-12.2012 · Cited by 79
Self-citationEffects of exercise stress on the endocannabinoid system in humans under field conditions
Feuerecker, M., Hauer, D., Tóth, R., Demetz, F., Hölzl, J., Thiel, M., Kaufmann, I., Schelling, G., & Choukèr, A. (2011) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2237-0 · Cited by 79
Metadata
- Authors
- Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D.
- Affiliations
- University of Georgia (US)
- University of California, Irvine (US)
- Brown University (US)
- University of Urbino (IT)
- University of Parma (IT)
- Corresponding author
- Hohmann, Andrea G.
- Piomelli, Daniele
- ORCID
- Venue
- Nature
- Published
- 2005-06
- Volume
- 435
- Issue
- 7045
- Pages
- 1108-1112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2030777873
- Cited by
- 778
- References
- 30
- Citations by year
- 2026: 14 · 2025: 24 · 2024: 22 · 2023: 22 · 2022: 28 · 2021: 26 · 2020: 22 · 2019: 20 · 2018: 29 · 2017: 53 · 2016: 34 · 2015: 38 · 2014: 40 · 2013: 33 · 2012: 45
- FWCI
- 39.98
- Type
- journal article
- Language
- en
- Open access
- green
- escholarship.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- stress-induced analgesia, endocannabinoid system, CB1 receptor, periaqueductal gray, 2-arachidonoylglycerol, anandamide, monoacylglycerol lipase, fatty acid amide hydrolase, opioid-independent analgesia, pain inhibition, stress-related disorders, therapeutic target
- MeSH terms
- Analgesia, Animals, Arachidonic Acids, Biological Transport, Biphenyl Compounds, Glycerides, Hydrolysis, Male, Mesencephalon, Monoacylglycerol Lipases, Stress, Physiological, Rats, Sprague-Dawley, Rats, Wistar, Receptor, Cannabinoid, CB1, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review